These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8341767

  • 21. Plasma homovanillic acid as a predictor of response to neuroleptics.
    Davila R, Manero E, Zumarraga M, Andia I, Schweitzer JW, Friedhoff AJ.
    Arch Gen Psychiatry; 1988 Jun; 45(6):564-7. PubMed ID: 3377643
    [Abstract] [Full Text] [Related]

  • 22. Brain contribution to the haloperidol-induced increase in plasma homovanillic acid.
    Kendler KS, Heninger GR, Roth RH.
    Eur J Pharmacol; 1981 May 08; 71(2-3):321-6. PubMed ID: 7250191
    [Abstract] [Full Text] [Related]

  • 23. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients.
    Chang WH, Lin SK, Jann MW, Lam YW, Chen TY, Chen CT, Hu WH, Yeh EK.
    Biol Psychiatry; 1989 Jul 08; 26(3):239-49. PubMed ID: 2742942
    [Abstract] [Full Text] [Related]

  • 24. Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume.
    Breier A, Davis OR, Buchanan RW, Moricle LA, Munson RC.
    Arch Gen Psychiatry; 1993 Jul 08; 50(7):541-50. PubMed ID: 8317948
    [Abstract] [Full Text] [Related]

  • 25. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
    Newcomer JW, Riney SJ, Vinogradov S, Csernansky JG.
    Psychiatry Res; 1992 Mar 08; 41(3):191-202. PubMed ID: 1594706
    [Abstract] [Full Text] [Related]

  • 26. Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia.
    Andia I, Zumarraga M, Zabalo MJ, Bulbena A, Davila R.
    Biol Psychiatry; 1998 Jan 01; 43(1):20-3. PubMed ID: 9442340
    [Abstract] [Full Text] [Related]

  • 27. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
    Brown AS, Gewirtz G, Harkavy-Friedman J, Cooper T, Brébion G, Amador XF, Malaspina D, Gorman JM.
    Neuropsychopharmacology; 1997 Nov 01; 17(5):317-25. PubMed ID: 9348547
    [Abstract] [Full Text] [Related]

  • 28. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
    Scatton B, Zarifian E, Bianchetti G, Cuche H, Loo H, Morselli PL.
    Encephale; 1982 Nov 01; 8(1):1-8. PubMed ID: 7094868
    [Abstract] [Full Text] [Related]

  • 29. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
    Konicki PE, Owen RR, Litman RE, Pickar D.
    Life Sci; 1991 Nov 01; 48(14):1411-6. PubMed ID: 2008157
    [Abstract] [Full Text] [Related]

  • 30. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R, Gonzalez MA, Zumarraga M, Andia I, Guimon J, Silva RR, Friedhoff AJ.
    Biol Psychiatry; 1995 Aug 15; 38(4):267-9. PubMed ID: 8547450
    [No Abstract] [Full Text] [Related]

  • 31. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM.
    Arch Gen Psychiatry; 1986 Jul 15; 43(7):669-76. PubMed ID: 3718170
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Acute and chronic effects of haloperidol on plasma and brain homovanillic acid in the rat.
    Chang WH, Yeh EK, Hu WH, Tseng YT, Chung MC, Chang HF.
    Biol Psychiatry; 1986 Apr 15; 21(4):374-81. PubMed ID: 3955111
    [Abstract] [Full Text] [Related]

  • 35. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.
    Pickar D, Labarca R, Linnoila M, Roy A, Hommer D, Everett D, Paul SM.
    Science; 1984 Aug 31; 225(4665):954-7. PubMed ID: 6474162
    [Abstract] [Full Text] [Related]

  • 36. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S, Iwamoto N, Arai H.
    Biol Psychiatry; 1997 Apr 15; 41(8):857-64. PubMed ID: 9099412
    [Abstract] [Full Text] [Related]

  • 37. Specific effect of haloperidol on dopamine turnover in the frontal cortex.
    Laduron P, de Bie K, Leysen J.
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan 15; 296(2):183-5. PubMed ID: 834317
    [Abstract] [Full Text] [Related]

  • 38. Plasma homovanillic acid concentration and the severity of schizophrenic illness.
    Davis KL, Davidson M, Mohs RC, Kendler KS, Davis BM, Johns CA, DeNigris Y, Horvath TB.
    Science; 1985 Mar 29; 227(4694):1601-2. PubMed ID: 3975630
    [Abstract] [Full Text] [Related]

  • 39. Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid.
    Aymard N, Viala A, Stein I, Caroli F.
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov 29; 19(7):1119-35. PubMed ID: 8787036
    [Abstract] [Full Text] [Related]

  • 40. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
    Akiyama K, Tsuchida K, Kanzaki A, Ujike H, Hamamura T, Kondo K, Mutoh S, Miyanagi K, Kuroda S, Otsuki S.
    Biol Psychiatry; 1995 Nov 15; 38(10):639-48. PubMed ID: 8555375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.